文献速递妇产影像泌尿生殖技术与安全US

IOTA简易规则、SRR评估、ADNEX模型与O-RADS在北美女性附件病变良恶性鉴别中的性能

Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
PubMed 文献 · Ultrasound Obstet Gynecol · 2022-04-08

单中心诊断准确性研究纳入150例附件病变女性,比较IOTA简易规则、SRR、ADNEX模型与O-RADS在术前鉴别良恶性的性能。以恶性风险阈值≥10%比较,ADNEX敏感度97.5%、特异度63.6%,SRR敏感度100%、特异度51.8%,O-RADS敏感度100%、特异度46.4%;SR可应用时敏感度100%、特异度95.6%,但37例不确定病例影响特异度。结论提示IOTA模型与O-RADS敏感度相似,但IOTA模型特异度更高且无需MRI。

要点

  • O-RADS 2或3类未见组织学证实的恶性病变,4类14例恶性,5类26例恶性。
  • SR可应用时特异度95.6%,不确定病例归为恶性则特异度降至79.1%。
  • ADNEX与SRR在恶性病变中的平均恶性风险显著高于良性病变。

诊断标准与关键数值

  • 以恶性风险阈值≥10%比较,ADNEX敏感度97.5%(95%CI 85.3%-99.9%)、特异度63.6%(95%CI 53.9%-72.4%)。
  • SRR敏感度100%(95%CI 89.1%-100%)、特异度51.8%(95%CI 42.1%-61.4%)。
  • SR可应用于113例,敏感度100%(95%CI 81.5%-100%)、特异度95.6%(95%CI 88.5%-98.6%)。
  • SR不确定的37例归为恶性后,敏感度100%、特异度79.1%(95%CI 70.1%-86.0%)。
  • O-RADS以≥10%为阈值,敏感度100%(95%CI 89.1%-100.0%)、特异度46.4%(95%CI 36.9%-56.1%)。

临床应用与阅片要点

  • O-RADS 2或3类在本队列无组织学证实的恶性病变,支持低风险分类的阴性预测价值。
  • SR可明确分类时特异度高,但需注意37例不确定病例的处理对特异度的影响。
  • IOTA模型与O-RADS敏感度相似,但IOTA模型特异度更高且不依赖MRI。

局限性

  • 单中心研究,样本量150例,外推性有限。
  • SR、SRR和O-RADS为回顾性应用,ADNEX为前瞻性分类,存在方法学差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To apply the International Ovarian Tumor Analysis (IOTA) Simple Rules (SR), the IOTA Simple Rules risk assessment (SRR), the IOTA Assessment of Different NEoplasias in the adneXa (ADNEX) model and the Ovarian-Adnexal Reporting and Data System (O-RADS) in the same cohort of North American patients and to compare their performance in preoperative discrimination between benign and malignant adnexal lesions.

METHODS: This was a single-center diagnostic accuracy study, performed between March 2018 and February 2021, which included 150 women with an adnexal lesion. Using the ADNEX model, lesions were classified prospectively, whereas the SR, SRR assessment and O-RADS were applied retrospectively. Surgery with histological analysis was performed within 6 months of the ultrasound exam. Sensitivity and specificity were determined for each testing modality and the performance of the different modalities was compared.

RESULTS: Of the 150 women, 110 (73.3%) had a benign ovarian tumor and 40 (26.7%) had a malignant tumor. The mean risk of malignancy generated by the ADNEX model without CA 125 was significantly higher in malignant vs benign lesions (63.3% vs 11.8%) and the area under the receiver-operating-characteristics curve (AUC) of the ADNEX model for differentiating between benign and malignant adnexal masses at the time of ultrasound examination was 0.937. The mean risk of malignancy generated by SRR assessment was also significantly higher in malignant vs benign lesions (74.1% vs 15.9%) and the AUC was 0.941. To compare the ADNEX model, SRR assessment and O-RADS, the malignancy risk threshold was set at ≥ 10%. This cut-off differentiates O-RADS low-risk categories (Category ≤ 3) from intermediate-to-high-risk categories (Categories 4 and 5). At this cut-off, the sensitivity of the ADNEX model was 97.5% (95% CI, 85.3%-99.9%) and the specificity was 63.6% (95% CI, 53.9%-72.4%), and, for the SRR model, the sensitivity was 100% (95% CI, 89.1%-100%) and the specificity was 51.8% (95% CI, 42.1%-61.4%). In the 113 cases to which the SR could be applied, the sensitivity was 100% (95% CI, 81.5%-100%) and the specificity was 95.6% (95% CI, 88.5%-98.6%). If the remaining 37 cases, which were inconclusive under SR, were designated 'malignant', the sensitivity remained at 100% but the specificity was reduced to 79.1% (95% CI, 70.1%-86.0%). The 150 cases fell into the following O-RADS categories: 17 (11.3%) lesions in Category 2, 34 (22.7%) in Category 3, 66 (44.0%) in Category 4 and 33 (22.0%) in Category 5. There were no histologically proven malignant lesions in Category 2 or 3. There were 14 malignant lesions in Category 4 and 26 in Category 5. The sensitivity of O-RADS using a malignancy risk threshold of ≥ 10% was 100% (95% CI, 89.1%-100.0%) and the specificity was 46.4% (95% CI, 36.9%-56.1%).

CONCLUSIONS: When IOTA terms and techniques are used, the performance of IOTA models in a North American patient population is in line with published IOTA results in other populations. The IOTA SR, SRR assessment and ADNEX model and O-RADS have similar sensitivity in the preoperative discrimination of malignant from benign pelvic tumors; however, the IOTA models have higher specificity and the algorithm does not require the use of magnetic resonance imaging. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Hiett AK, Sonek JD, Guy M, et al. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women. Ultrasound Obstet Gynecol. 2022. PMID: 34533862. doi:10.1002/uog.24777

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。